《全日總結》恆指升768點 科網、消費及藥股揚 騰訊彈一成
市場憧憬內地研究放寬防疫政策,港股今日反覆向上。恆指高開172點後升幅擴大,曾升945點一度高見15,632點,全日升768點或5.23%,收15,455點;國指升271點或5.49%,收5,209點;恆生科技指數升222點或7.8%,收3,075點。大市全日成交總額1,538.12億元,滬、深港通南下交易淨流入37.6億及53.07億元人民幣。
科技股反彈,騰訊(00700.HK)升10.6%報227.4元,阿里巴巴(09988.HK)升7.6%報66.1元,小米(01810.HK)升5%報9.25元,美團(03690.HK)升11.9%報139.6元,京東(09618.HK)升8.4%報157.3元,網易(09999.HK)及百度(09888.HK)各升7.8%及7.5%,快手(01024.HK)及明源雲(00909.HK)各升15%及16.3%,眾安在線(06060.HK)及嗶哩嗶哩(09626.HK)各升10.1%及11.5%。手機部件股瑞聲(02018.HK)升8.2%,丘鈦(01478.HK)及舜宇(02382.HK)各升12.9%及10.3%。
消費股回升,呷哺呷哺(00520.HK)、海底撈(06862.HK)、貓眼娛樂(01896.HK)、九毛九(09922.HK)、頤海(01579.HK)、潤啤(00291.HK)及青啤(00168.HK)各升10.3%至13%,中國飛鶴(06186.HK)、蒙牛(02319.HK)、百勝中國(09987.HK)及李寧(02331.HK)各升8%至9.5%。旅遊平台攜程(09961.HK)及同程旅行(00780.HK)各升12%及9.3%。濠賭股銀娛(00027.HK)升8.8%,新濠國際(00200.HK)、永利澳門(01128.HK)、金沙中國(01928.HK)及美高梅中國(02282.HK)各升逾一成。
醫藥股康希諾(06185.HK)炒升18.2%,中生製藥(01177.HK)、復星醫藥(02196.HK)、藥明康德(02359.HK)、石藥(01093.HK)及翰森(03692.HK)各升8.7%至10%,潤藥(03320.HK)及百濟神州(06160.HK)各升7.9%及7.6%。
友邦(01299.HK)第三季新業務價值按固定匯率計升7%,全日股價升6.6%報63.4元。匯控(00005.HK)升2%報41.05元,港交所(00388.HK)升8.3%。招行(03968.HK)及太保(02601.HK)各升8.7%及5.7%,中國平安(02318.HK)升4.6%。內房股旭輝(00884.HK)終止與境外債權人延遲還款討論,暫停支付本息,該股挫25%。
龍湖(00960.HK)以近20億人幣投得蘇州第四批集中供地其中一塊地皮,該股反彈8.2%。物管股碧服(06098.HK)及華潤萬象(01209.HK)各升6.6%及10.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.